The effect of orally administered prostaglandin E2 and its synthetic 15-methyl analogues on gastric secretion in man was studied. The parent E, compound did not inhibit basal secretion,whereas both the 15 (S) 15-methyl-E, methyl ester and its isomer, 15 (R) 15-methyl-E, methyl ester inhibited basal acid secretion. This action is likely to be a direct one on the parietal cell, and it could prove of value in the treatment of peptic ulcer.
Introduction
The inhibition of gastric acid secretion in man by intravenous infusion of prostaglandins El (PGE,), E2 (PGE,) , and Al (PGA1) has been reported by several investigators (Classen et al., 1970; Wada and Ishizawa, 1970; Wilson et al., 1971) . While PGE1 in contact with gastric mucosa inhibited acid production in anaesthetized rats (Ramwell and Shaw, 1968) and in isolated bullfrog mucosa preparations (Way and Durbin, 1969) there have been no reports of locally administered prostaglandins having a similar effect in man. On the contrary, Horton et al. (1968) found that in man orally administered PGE1 had no effect on pentagastrin-induced acid secretion.
A possible explanation for the lack of effect of orally administered naturally occurring prostaglandins on acid secretion is their rapid enzymatic inactivation and metabolism. One of the most important points in the metabolism of naturally occurring prostaglandins is dehydrogenation at carbon 15, which is brought about by the enzyme prostaglandin 15-OH dehydrogenase. This metabolism occurs very readily and the resulting compounds possess a greatly reduced biological activity. Prost- aglandin analogues modified at carbon 15 have now been synthesized (Bundy et al., 1971 ; Yankee and Bundy, 1972) . Two such compounds are prostaglandin 15 (S) 15-methyl-E, methyl ester and its isomer 15 (R) 15-methyl-E2 methyl ester ( fig. 1 ). These analogues are not substrates for enzyme prostaglandin 15-OH dehydrogenase and consequently enzymic de- gradation at carbon 15 is prevented. The increase in some of the biological actions of analogues with modification at carbon 15 has been confirmed Karim et al., 1972a; Kirton and Forbes, 1972 After a 12-hour overnight fast a nasogastric tube (F.G. 14-16) was passed into the stomach. The fasting residue was discarded and the tube position adjusted to allow the ready recovery of a trial 20 ml instillate of water. Although continuous suction was applied tube patency was also ensured by periodic air insufflation. Specimens of gastric juice were collected every 15 minutes and assessed in terms of volume (ml), pH, acid concentration (mEq/l.), and acid output (mEq). Titrations were performed to end-point pH 7 by using a glass electrode and 0-05N NaOH solution. After a basal period of two 15-minute collections the prostaglandin was given by instillation down the nasogastric tube in 10 ml of water. Aspiration was discontinued for 30 minutes to allow contact with the gastric mucosa. Collection was then restarted for a further three hours. The control studies differed only in that prostaglandins were excluded from the instillate.
Subjects were questioned specifically about untoward gastrointestinal and other side effects during the test and asked to report any alterations in bowel habit in the succeeding 24 hours.
Results

PROSTAGLANDIN E2
Of the seven tests carried out with the parent compound three were performed using 2-5 mg orally and four with a dose of 4 mg. In view of the recognized side effects of oral PGE2 it was deemed unwise to use a higher dosage (Karim, 1971 compound. The reduction in acid secretion was mediated primarily by a fall in acid concentration as no consistent alteration in the volume of the aspirate was noted. It was a subjective impression that viscosity of the gastric mucus was increased after exposure to the analogue, and it is possible that the inhibitory effect on acid production did not extend to the nonparietal component of gastric secretion.
Although the 15 (S) 15-methyl-E2 methyl ester compound showed a similar effect on basal secretion its use in this context is limited by its recognized excitatory effect on smooth muscle, in particular that of the uterus. Even in the limited dose range explored some unpleasant gastrointestinal symptoms were reported, and for these reasons the compound was not examined further once the broad pattern of response had been established. The 15 (R) analogue, on the other hand, appeared free from side effects and its uterine actions by the oral route are also known to be less marked.
The failure of the parent E2 compound to inhibit basal acid secretion is probably due to its rapid metabolism and inactivation. The 15-methyl derivatives are some 100 to 500 times more active and their duration of action on the uterus is longer by a factor of 3 to 4 when compared with the parent prostaglandin . When given in high doses by intravenous infusion PGE, has been reported as having an inhibitory effect on acid production but only at the expense of an appr&iable incidence of undesirable sequelae (Wada and Ishizawa, 1970) . It is therefore highly unlikely that PGE2 will ever enjoy a therapeutic role in the suppression of acid secretion.
It has been suggested that the inhibition of gastric secretion by prostaglandins is due to a reduction in mucosal blood flow. While it is accepted that both the A and E series of compounds have a peripheral vasodilatory action the doses used in the present study had no effect on the blood pressure recorded by brachial artery cannulation (Karim et al., 1972 b) . In addition Jacobson (1970) , working with dogs, showed that the inhibitory effect of PGE1 was not due to a primary action on mucosal blood flow. While inhibition may result from changes in cyclic AMP concentrations it is also possible that there may be a direct action on the parietal cell. This last mechanism is supported by the observations that other prostaglandin fractions are capable of suppressing the secretion induced by histamine, pentagastrin, and vagal excitation (Ramwell and Shaw, 1968; Robert et al., 1968 a; Main, 1969; Wilson et al., 1971) . These mechanisms of inducing acid secretion are currently being challenged in our laboratory by the 15 (R) 15-methyl-E. methyl ester and the results will be published in detail separately. Our preliminary experience is that the compound is very effective in the reduction of pentagastrin-induced acid secretion.
The main interest in the present report lies in the fact that for the first time an oral preparation of prostaglandin has been shown to inhibit acid production. Of the two synthetic analogues the 15 (R) isomer shows the greater promise in that the effect is apparently free from side effects. The oral route of administration has obvious advantages if the analogue is to have therapeutic application to the problem of peptic ulceration, and we have had similar results after giving the dose in a hard gelatin capsule. The vehicle of 10 ml of water described here was used to ensure adequate contact with the secretory mucosa although it is possible that the contact time of 30 minutes does not allow complete absorption. In this context we have not attempted to measure the amount of prostaglandin returning with the aspirate, and it is possible that the doses used may give an artificially high impression of the. amount of prostaglandin producing the observed effect.
In experimental animals Robert et al. (1968 Robert et al. ( b, 1971 Investigations were: haemoglobin 12 7 g/100 ml, white cell count 7,000/mm3, packed cell volume 41%, E.S.R. 25 mm in 1 hr, plasma urea 46 mg/100 ml, creatinine 1 1 mg/100 ml, sodium 140 mEq/l., potassium 4 0 mEq/l., bicarbonate 26 mEq/l., total protein 7-6 g/100 ml, calcium 9-6 mg/100 ml, phosphate 2-4 mg/100 ml, uric acid 8-1 mg/100 ml, 24-hour creatinine clearance 75 ml/min, 24-hour calcium excretion 85 and 84 mg, 24-hour urinary uric acid excretion 370 and 360 mg.
An intravenous pyelogram showed that the kidneys concentrated well and that the upper urinary tract was normal. There was a 1-cm low density calculus in the pelvic portion of the left lower ureter. The bladder was slightly trabeculated with a moderate residue after micturition.
A radioactive renogram with 20 ,uCi of 1311 Hippuran and a urine flow rate of 4 ml/min showed a normal curve for the right kidney with no excretory abnormality. The left kidney showed considerably less good function with evidence of an obstructive lesion with a very slow excretory phase.
The day after the intravenous pyeolography the patient had a severe suprapubic pain eventually radiating to the left flank. This continued for two days and he then passed the calculus that we had seen in the pelvic portion of the left ureter.
STONE ANALYSIS
Quantitative stone analysis was carried out by using the system of Westbury and Omenogor (1970) , but as extended by Westbury (1972) to include oxalate determination. In addition, the usual qualitative tests were performed (see table) . It was also noted that the powdered material was insoluble in dilute HCI but was soluble in dilute NaOH, and could be precipitated from this solution on acidification with HCI, and that the fresh precipitate was soluble in further excess HC1. These reactions are those of silica, the presence of which was therefore suspected. The confirmation of this suspicion was sought by x-ray crystallography. Silica occurs in calculi in the opaline state which is non-crystalline, but on heating it can be transformed into various crystalline forms depending on the temperature of ignition. The x-ray powder diffraction method was therefore used to determine if any crystalline material was present in the stone. Small samples from
